These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24962347)

  • 1. A simple and rapid method to characterize lipid fate in skeletal muscle.
    Massart J; Zierath JR; Chibalin AV
    BMC Res Notes; 2014 Jun; 7():391. PubMed ID: 24962347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetyl-CoA carboxylase 2 inhibition reduces skeletal muscle bioactive lipid content and attenuates progression of type 2 diabetes in Zucker diabetic fatty rats.
    Takagi H; Ikehara T; Hashimoto K; Tanimoto K; Shimazaki A; Kashiwagi Y; Sakamoto S; Yukioka H
    Eur J Pharmacol; 2021 Nov; 910():174451. PubMed ID: 34454928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.
    Bursell SE; Takagi C; Clermont AC; Takagi H; Mori F; Ishii H; King GL
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2711-20. PubMed ID: 9418723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perilipin 5 fine-tunes lipid oxidation to metabolic demand and protects against lipotoxicity in skeletal muscle.
    Laurens C; Bourlier V; Mairal A; Louche K; Badin PM; Mouisel E; Montagner A; Marette A; Tremblay A; Weisnagel JS; Guillou H; Langin D; Joanisse DR; Moro C
    Sci Rep; 2016 Dec; 6():38310. PubMed ID: 27922115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilinoleoyl-phosphatidic acid mediates reduced IRS-1 tyrosine phosphorylation in rat skeletal muscle cells and mouse muscle.
    Cazzolli R; Mitchell TW; Burchfield JG; Pedersen DJ; Turner N; Biden TJ; Schmitz-Peiffer C
    Diabetologia; 2007 Aug; 50(8):1732-42. PubMed ID: 17593346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diacylglycerol kinase ε deficiency preserves glucose tolerance and modulates lipid metabolism in obese mice.
    Mannerås-Holm L; Schönke M; Brozinick JT; Vetterli L; Bui HH; Sanders P; Nascimento EBM; Björnholm M; Chibalin AV; Zierath JR
    J Lipid Res; 2017 May; 58(5):907-915. PubMed ID: 28246337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R59949, a diacylglycerol kinase inhibitor, inhibits inducible nitric oxide production through decreasing transplasmalemmal L-arginine uptake in vascular smooth muscle cells.
    Shimomura T; Nakano T; Goto K; Wakabayashi I
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):207-214. PubMed ID: 27909743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression of type I diacylglycerol kinases in pancreatic β-cells from male mice results in impaired insulin secretion.
    Kurohane Kaneko Y; Kobayashi Y; Motoki K; Nakata K; Miyagawa S; Yamamoto M; Hayashi D; Shirai Y; Sakane F; Ishikawa T
    Endocrinology; 2013 Nov; 154(11):4089-98. PubMed ID: 24035999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diacylglycerol kinase θ: regulation and stability.
    Tu-Sekine B; Goldschmidt H; Petro E; Raben DM
    Adv Biol Regul; 2013 Jan; 53(1):118-26. PubMed ID: 23266086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells.
    Du X; Jiang Y; Qian W; Lu X; Walsh JP
    Biochem J; 2001 Jul; 357(Pt 1):275-82. PubMed ID: 11415460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of thrombin-induced Ca²⁺ influx in platelets by R59949, an inhibitor of diacylglycerol kinase.
    Marumo M; Nakano T; Takeda Y; Goto K; Wakabayashi I
    J Pharm Pharmacol; 2012 Jun; 64(6):855-61. PubMed ID: 22571264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diacylglycerol kinase epsilon is selective for both acyl chains of phosphatidic acid or diacylglycerol.
    Lung M; Shulga YV; Ivanova PT; Myers DS; Milne SB; Brown HA; Topham MK; Epand RM
    J Biol Chem; 2009 Nov; 284(45):31062-73. PubMed ID: 19744926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluations of the selectivities of the diacylglycerol kinase inhibitors R59022 and R59949 among diacylglycerol kinase isozymes using a new non-radioactive assay method.
    Sato M; Liu K; Sasaki S; Kunii N; Sakai H; Mizuno H; Saga H; Sakane F
    Pharmacology; 2013; 92(1-2):99-107. PubMed ID: 23949095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diacylglycerol kinase ζ: at the crossroads of lipid signaling and protein complex organization.
    Rincón E; Gharbi SI; Santos-Mendoza T; Mérida I
    Prog Lipid Res; 2012 Jan; 51(1):1-10. PubMed ID: 22067957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the involvement of diacylglycerol kinase in the activation of hypoxia-inducible transcription factor 1 by low oxygen tension.
    Aragonés J; Jones DR; Martin S; San Juan MA; Alfranca A; Vidal F; Vara A; Mérida I; Landázuri MO
    J Biol Chem; 2001 Mar; 276(13):10548-55. PubMed ID: 11136721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diacylglycerol kinase-zeta localization in skeletal muscle is regulated by phosphorylation and interaction with syntrophins.
    Abramovici H; Hogan AB; Obagi C; Topham MK; Gee SH
    Mol Biol Cell; 2003 Nov; 14(11):4499-511. PubMed ID: 14551255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where do substrates of diacylglycerol kinases come from? Diacylglycerol kinases utilize diacylglycerol species supplied from phosphatidylinositol turnover-independent pathways.
    Sakane F; Mizuno S; Takahashi D; Sakai H
    Adv Biol Regul; 2018 Jan; 67():101-108. PubMed ID: 28918129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DGKζ deficiency protects against peripheral insulin resistance and improves energy metabolism.
    Benziane B; Borg ML; Tom RZ; Riedl I; Massart J; Björnholm M; Gilbert M; Chibalin AV; Zierath JR
    J Lipid Res; 2017 Dec; 58(12):2324-2333. PubMed ID: 29066466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of diacylglycerol kinase theta mediates adenosine-dependent hepatocyte preconditioning.
    Baldanzi G; Alchera E; Imarisio C; Gaggianesi M; Dal Ponte C; Nitti M; Domenicotti C; van Blitterswijk WJ; Albano E; Graziani A; Carini R
    Cell Death Differ; 2010 Jun; 17(6):1059-68. PubMed ID: 20057501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effect of reduced type I diacylglycerol kinase activity on insulin secretion from MIN6 β-cells.
    Sawatani T; Kaneko YK; Ishikawa T
    J Pharmacol Sci; 2019 Jun; 140(2):178-186. PubMed ID: 31279581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.